In summary, our study revealed that overexpression of miR-326 can inhibit cell proliferation, migration and invasion in prostate cancer cell line by regulating CKAP2L expression, which can be further investigated as a potential treatment target and a novel diagnosis marker. Here, CKAP2L is linked to prostate cancer.